Literature DB >> 1404473

AIDS/HIV crisis in developing countries: the need for greater understanding and innovative health promotion approaches.

I L Livingston1.   

Abstract

Epidemiologic data on morbidity and mortality have shown that the acquired immunodeficiency syndrome/human immunodeficiency virus (AIDS/HIV) epidemic is relatively widespread in the developing countries of the world, especially in the already economically deprived regions of Sub-Saharan Africa. Africa is estimated to have approximately 5 million seropositive individuals, and by the year 2000, this number is expected to include 10 million HIV-infected children. Improved control over this epidemic can only come through a greater understanding of the specifics of the disease and, eventually, the introduction of more effective and innovative health promotion campaigns targeted at medical personnel, traditional healers, families, and persons with AIDS. Comprehensive health promotion campaigns, carefully using mass media strategies in addition to more community-based programs, all operating under "decentralized" AIDS control programs, are reasoned to be the most efficacious approach that African and other developing countries can use to successfully contain the AIDS/HIV epidemic. Given the reality of the following factors: Pattern II (ie, transmission of AIDS via heterosexual sexual activity) is the main mode of HIV transmission in Africa, the traditional dominant roles males have in sexual relations, and the positive relationship between sexually transmitted diseases and AIDS, health promotion campaigns must focus specifically on addressing at-risk culturally related sexual values and behaviors in African communities. Failure to address these and other related factors will certainly lead to an escalation of the AIDS/HIV epidemic in Africa and, therefore, concomitant devastation in the human and societal realms of the region.

Entities:  

Mesh:

Year:  1992        PMID: 1404473      PMCID: PMC2571774     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  28 in total

1.  A presidential health mission to Africa.

Authors:  L W Sullivan
Journal:  Public Health Rep       Date:  1991 Mar-Apr       Impact factor: 2.792

Review 2.  AIDS: the community-based response.

Authors:  J F McGuire
Journal:  AIDS       Date:  1989       Impact factor: 4.177

3.  Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire.

Authors:  R W Ryder; W Nsa; S E Hassig; F Behets; M Rayfield; B Ekungola; A M Nelson; U Mulenda; H Francis; K Mwandagalirwa
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

Review 4.  Co-factors, host susceptibility, and AIDS: an argument for stress.

Authors:  I L Livingston
Journal:  J Natl Med Assoc       Date:  1988-01       Impact factor: 1.798

Review 5.  Heterosexual transmission of HIV.

Authors:  P Piot; J K Kreiss; J O Ndinya-Achola; E N Ngugi; J N Simonsen; D W Cameron; H Taelman; F A Plummer
Journal:  AIDS       Date:  1987-12       Impact factor: 4.177

6.  Channeling health: a review of the evaluation of televised health campaigns.

Authors:  R Lau; R Kane; S Berry; J Ware; D Roy
Journal:  Health Educ Q       Date:  1980

Review 7.  Behavioral and psychological responses to HIV antibody testing.

Authors:  P B Jacobsen; S W Perry; D A Hirsch
Journal:  J Consult Clin Psychol       Date:  1990-02

8.  The psychosocial and neuropsychiatric sequelae of the acquired immunodeficiency syndrome and related disorders.

Authors:  J C Holland; S Tross
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

9.  Postnatal transmission of AIDS-associated retrovirus from mother to infant.

Authors:  J B Ziegler; D A Cooper; R O Johnson; J Gold
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

Review 10.  Hypertension and health education intervention in the Caribbean: a public health appraisal.

Authors:  I L Livingston
Journal:  J Natl Med Assoc       Date:  1985-04       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.